|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 498/04 | |
| C07F 9/6561 | |||
| A61K 31/5383 | |||
| A61K 31/675 | |||
| A61P 37/00 |
| (11) | Patento numeris | 2078026 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07864696.5 |
| Europos patento paraiškos padavimo data | 2007-11-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-07-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-01-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/085313 |
| Data | 2007-11-20 |
| (87) | Numeris | WO 2008/064274 |
| Data | 2008-05-29 |
| (30) | Numeris | Data | Šalis |
| 866722 P | 2006-11-21 | US |
| (72) |
BHAMIDIPATI, Somasekhar, US
SINGH, Rajinder, US
SUN, Thomas, US
MASUDA, Esteban, US
|
| (73) |
Rigel Pharmaceuticals, Inc.,
1180 Veterans Boulevard, South San Francisco, CA 94080,
US
|
| (54) | PRODRUG SALTS OF 2, 4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES |
| PRODRUG SALTS OF 2, 4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES |